High Risk of Early Neurological Recurrence in Symptomatic Carotid Stenosis

Background and Purpose— Few data are available on very early stroke recurrence evaluated within the first hours after onset of symptoms and outcome for unselected patients with first-ever mild stroke or TIA and symptomatic carotid stenosis ≥50%. Methods— One hundred sixty-three patients with symptom...

Full description

Saved in:
Bibliographic Details
Published inStroke (1970) Vol. 40; no. 8; pp. 2727 - 2731
Main Authors Ois, Angel, Cuadrado-Godia, Elisa, Rodríguez-Campello, Ana, Jimenez-Conde, Jordi, Roquer, Jaume
Format Journal Article
LanguageEnglish
Published Hagerstown, MD Lippincott Williams & Wilkins 01.08.2009
Subjects
Online AccessGet full text
ISSN0039-2499
1524-4628
1524-4628
DOI10.1161/STROKEAHA.109.548032

Cover

Abstract Background and Purpose— Few data are available on very early stroke recurrence evaluated within the first hours after onset of symptoms and outcome for unselected patients with first-ever mild stroke or TIA and symptomatic carotid stenosis ≥50%. Methods— One hundred sixty-three patients with symptomatic carotid stenosis and initial mild stroke (121) or TIA (42) were evaluated within 6 hours from onset of symptoms in a single tertiary hospital. Neurological recurrence (NR) was defined as a clearly defined new neurological event (TIA or stroke) or an increase of 4 points in the initial NIHSS. The NR rate was determined at 72 hours, 7 days, and 14 days. Disability was defined as a score of 3 to 6 on the modified Rankin scale at 14 days. Results— Forty-five patients (27.6%) had NR, including 6 patients with 2 episodes in different time periods: 34 (20.9%) within the first 72 hours; 11 (6.7%) between 72 hours and 7 days; and 6 (3.7%) at 14 days. Only carotid stenosis ≥70% was associated with NR; diabetes was marginally associated. At 2 weeks, 19 patients (11.7%) had disability; 14 of them experienced NR in the first 72 hours. Conclusions— Patients with first-ever mild stroke or TIA and symptomatic carotid stenosis are at high risk for NR, especially within the first 72 hours. Our results suggest the necessity of testing pharmacological or interventional strategies for use during the hyperacute stroke phase in these patients.
AbstractList Background and Purpose— Few data are available on very early stroke recurrence evaluated within the first hours after onset of symptoms and outcome for unselected patients with first-ever mild stroke or TIA and symptomatic carotid stenosis ≥50%. Methods— One hundred sixty-three patients with symptomatic carotid stenosis and initial mild stroke (121) or TIA (42) were evaluated within 6 hours from onset of symptoms in a single tertiary hospital. Neurological recurrence (NR) was defined as a clearly defined new neurological event (TIA or stroke) or an increase of 4 points in the initial NIHSS. The NR rate was determined at 72 hours, 7 days, and 14 days. Disability was defined as a score of 3 to 6 on the modified Rankin scale at 14 days. Results— Forty-five patients (27.6%) had NR, including 6 patients with 2 episodes in different time periods: 34 (20.9%) within the first 72 hours; 11 (6.7%) between 72 hours and 7 days; and 6 (3.7%) at 14 days. Only carotid stenosis ≥70% was associated with NR; diabetes was marginally associated. At 2 weeks, 19 patients (11.7%) had disability; 14 of them experienced NR in the first 72 hours. Conclusions— Patients with first-ever mild stroke or TIA and symptomatic carotid stenosis are at high risk for NR, especially within the first 72 hours. Our results suggest the necessity of testing pharmacological or interventional strategies for use during the hyperacute stroke phase in these patients.
Few data are available on very early stroke recurrence evaluated within the first hours after onset of symptoms and outcome for unselected patients with first-ever mild stroke or TIA and symptomatic carotid stenosis > or =50%.BACKGROUND AND PURPOSEFew data are available on very early stroke recurrence evaluated within the first hours after onset of symptoms and outcome for unselected patients with first-ever mild stroke or TIA and symptomatic carotid stenosis > or =50%.One hundred sixty-three patients with symptomatic carotid stenosis and initial mild stroke (121) or TIA (42) were evaluated within 6 hours from onset of symptoms in a single tertiary hospital. Neurological recurrence (NR) was defined as a clearly defined new neurological event (TIA or stroke) or an increase of 4 points in the initial NIHSS. The NR rate was determined at 72 hours, 7 days, and 14 days. Disability was defined as a score of 3 to 6 on the modified Rankin scale at 14 days.METHODSOne hundred sixty-three patients with symptomatic carotid stenosis and initial mild stroke (121) or TIA (42) were evaluated within 6 hours from onset of symptoms in a single tertiary hospital. Neurological recurrence (NR) was defined as a clearly defined new neurological event (TIA or stroke) or an increase of 4 points in the initial NIHSS. The NR rate was determined at 72 hours, 7 days, and 14 days. Disability was defined as a score of 3 to 6 on the modified Rankin scale at 14 days.Forty-five patients (27.6%) had NR, including 6 patients with 2 episodes in different time periods: 34 (20.9%) within the first 72 hours; 11 (6.7%) between 72 hours and 7 days; and 6 (3.7%) at 14 days. Only carotid stenosis > or =70% was associated with NR; diabetes was marginally associated. At 2 weeks, 19 patients (11.7%) had disability; 14 of them experienced NR in the first 72 hours.RESULTSForty-five patients (27.6%) had NR, including 6 patients with 2 episodes in different time periods: 34 (20.9%) within the first 72 hours; 11 (6.7%) between 72 hours and 7 days; and 6 (3.7%) at 14 days. Only carotid stenosis > or =70% was associated with NR; diabetes was marginally associated. At 2 weeks, 19 patients (11.7%) had disability; 14 of them experienced NR in the first 72 hours.Patients with first-ever mild stroke or TIA and symptomatic carotid stenosis are at high risk for NR, especially within the first 72 hours. Our results suggest the necessity of testing pharmacological or interventional strategies for use during the hyperacute stroke phase in these patients.CONCLUSIONSPatients with first-ever mild stroke or TIA and symptomatic carotid stenosis are at high risk for NR, especially within the first 72 hours. Our results suggest the necessity of testing pharmacological or interventional strategies for use during the hyperacute stroke phase in these patients.
Few data are available on very early stroke recurrence evaluated within the first hours after onset of symptoms and outcome for unselected patients with first-ever mild stroke or TIA and symptomatic carotid stenosis > or =50%. One hundred sixty-three patients with symptomatic carotid stenosis and initial mild stroke (121) or TIA (42) were evaluated within 6 hours from onset of symptoms in a single tertiary hospital. Neurological recurrence (NR) was defined as a clearly defined new neurological event (TIA or stroke) or an increase of 4 points in the initial NIHSS. The NR rate was determined at 72 hours, 7 days, and 14 days. Disability was defined as a score of 3 to 6 on the modified Rankin scale at 14 days. Forty-five patients (27.6%) had NR, including 6 patients with 2 episodes in different time periods: 34 (20.9%) within the first 72 hours; 11 (6.7%) between 72 hours and 7 days; and 6 (3.7%) at 14 days. Only carotid stenosis > or =70% was associated with NR; diabetes was marginally associated. At 2 weeks, 19 patients (11.7%) had disability; 14 of them experienced NR in the first 72 hours. Patients with first-ever mild stroke or TIA and symptomatic carotid stenosis are at high risk for NR, especially within the first 72 hours. Our results suggest the necessity of testing pharmacological or interventional strategies for use during the hyperacute stroke phase in these patients.
Author Roquer, Jaume
Ois, Angel
Cuadrado-Godia, Elisa
Rodríguez-Campello, Ana
Jimenez-Conde, Jordi
Author_xml – sequence: 1
  givenname: Angel
  surname: Ois
  fullname: Ois, Angel
  organization: From the Servei de Neurologia, Hospital del Mar, IMAS, IMIM, Universidad Autonoma de Barcelona, Barcelona, Spain
– sequence: 2
  givenname: Elisa
  surname: Cuadrado-Godia
  fullname: Cuadrado-Godia, Elisa
  organization: From the Servei de Neurologia, Hospital del Mar, IMAS, IMIM, Universidad Autonoma de Barcelona, Barcelona, Spain
– sequence: 3
  givenname: Ana
  surname: Rodríguez-Campello
  fullname: Rodríguez-Campello, Ana
  organization: From the Servei de Neurologia, Hospital del Mar, IMAS, IMIM, Universidad Autonoma de Barcelona, Barcelona, Spain
– sequence: 4
  givenname: Jordi
  surname: Jimenez-Conde
  fullname: Jimenez-Conde, Jordi
  organization: From the Servei de Neurologia, Hospital del Mar, IMAS, IMIM, Universidad Autonoma de Barcelona, Barcelona, Spain
– sequence: 5
  givenname: Jaume
  surname: Roquer
  fullname: Roquer, Jaume
  organization: From the Servei de Neurologia, Hospital del Mar, IMAS, IMIM, Universidad Autonoma de Barcelona, Barcelona, Spain
BackLink http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=21782441$$DView record in Pascal Francis
https://www.ncbi.nlm.nih.gov/pubmed/19498196$$D View this record in MEDLINE/PubMed
BookMark eNp9kU9P4zAQxS0Eghb4Bmjly3JL8f_Ye6uqst0FgdTC2XJtB7wkcbGTQ789Qe32wIHTSKPfm5k3bwyO29h6AK4wmmAs8M3qafl4N58uphOM1IQziSg5AiPMCSuYIPIYjBCiqiBMqTMwzvkfQohQyU_BGVZMSazECPxdhJdXuAz5DcYKzk2qt_DB9ynW8SVYU8Olt31KvrUehhauts2mi43pgoUzk2IXHFx1vo055AtwUpk6-8t9PQfPt_On2aK4f_z9Zza9LyyjZVcQpwShmHLDnaSoRE445qzDmFrpsOKe0rWiVKyF5EQR46ygpjIScSbKQXgOrndzNym-9z53ugnZ-ro2rY991qLkdHgCGcAfe7BfN97pTQqNSVv93_0A_NwDJg9eq2RaG_KBI7iUhLHPjb92nE0x5-QrbUM3_CC2XTKh1hjpz0j0IZKho_QukkHMvogPd3wn-wC8Fo31
CODEN SJCCA7
CitedBy_id crossref_primary_10_1111_ene_13876
crossref_primary_10_1016_j_jstrokecerebrovasdis_2017_08_008
crossref_primary_10_3171_2013_7_JNS122128
crossref_primary_10_1016_j_ejvs_2011_11_008
crossref_primary_10_1111_eci_13318
crossref_primary_10_1016_j_ejvs_2015_01_007
crossref_primary_10_33529_angio2019203
crossref_primary_10_1177_1747493015609777
crossref_primary_10_1212_WNL_0b013e31829e6f37
crossref_primary_10_1136_svn_2017_000073
crossref_primary_10_1016_j_ejvs_2014_11_004
crossref_primary_10_1136_pn_2023_003918
crossref_primary_10_1212_WNL_0000000000200525
crossref_primary_10_1024_1661_8157_a003475
crossref_primary_10_1212_WNL_0000000000001780
crossref_primary_10_1016_j_ejvs_2015_01_011
crossref_primary_10_1111_j_1468_1331_2011_03452_x
crossref_primary_10_2176_nmc_oa_2016_0236
crossref_primary_10_1016_j_jvs_2024_08_014
crossref_primary_10_1016_j_surge_2010_01_006
crossref_primary_10_1016_j_jocn_2023_05_024
crossref_primary_10_1212_WNL_0000000000002354
crossref_primary_10_1007_s10143_016_0737_4
crossref_primary_10_1016_j_atherosclerosis_2011_07_114
crossref_primary_10_1186_s12883_020_01907_w
crossref_primary_10_1111_ene_13017
crossref_primary_10_1007_s00234_020_02546_1
crossref_primary_10_1016_j_ejvs_2011_08_004
crossref_primary_10_3310_hta18270
crossref_primary_10_1212_WNL_0000000000004486
crossref_primary_10_1016_j_ejvs_2016_01_022
crossref_primary_10_1161_STROKEAHA_120_032410
crossref_primary_10_1177_15910199241239204
crossref_primary_10_1016_j_clineuro_2014_10_008
crossref_primary_10_1016_j_ejvs_2022_04_011
crossref_primary_10_1016_j_jvs_2022_09_018
crossref_primary_10_1007_s43678_024_00759_4
crossref_primary_10_1136_bjophthalmol_2013_304316
crossref_primary_10_1161_STR_0000000000000211
crossref_primary_10_1016_j_ejvs_2013_07_015
crossref_primary_10_1016_j_jns_2023_120578
crossref_primary_10_1007_s00772_015_0105_7
crossref_primary_10_1016_j_ejvs_2011_10_016
crossref_primary_10_1016_j_jvs_2013_08_035
crossref_primary_10_1136_neurintsurg_2015_012088
crossref_primary_10_1016_j_wneu_2018_04_199
crossref_primary_10_1007_s11886_021_01593_1
crossref_primary_10_3174_ajnr_A3144
crossref_primary_10_1515_revneuro_2024_0002
crossref_primary_10_1017_S0959259810000419
crossref_primary_10_1016_j_avsg_2022_08_018
crossref_primary_10_1016_j_ejvs_2017_06_021
crossref_primary_10_1093_neuros_nyaa096
crossref_primary_10_1016_j_jvs_2010_09_015
crossref_primary_10_1186_1471_2377_14_23
crossref_primary_10_1586_14779072_2015_1088781
crossref_primary_10_1016_j_jvs_2010_09_016
crossref_primary_10_23736_S0021_9509_24_13093_5
crossref_primary_10_1186_s13643_016_0388_0
crossref_primary_10_1016_j_clineuro_2020_105855
crossref_primary_10_1016_j_ejvs_2012_02_002
crossref_primary_10_1016_j_jstrokecerebrovasdis_2014_05_003
crossref_primary_10_1016_S1853_0028_11_70006_4
crossref_primary_10_1007_s00415_011_5909_0
crossref_primary_10_1016_j_jstrokecerebrovasdis_2021_106182
crossref_primary_10_1016_j_ejvs_2010_10_017
crossref_primary_10_1016_j_ejvs_2014_09_006
crossref_primary_10_1016_j_jvs_2022_02_040
crossref_primary_10_1111_j_1747_4949_2012_00790_x
crossref_primary_10_1016_j_amjcard_2019_05_013
crossref_primary_10_1016_j_jvs_2023_10_041
crossref_primary_10_1016_j_avsg_2024_09_041
crossref_primary_10_1016_j_jvs_2020_02_024
crossref_primary_10_1016_j_jvs_2015_02_046
crossref_primary_10_1097_SLA_0000000000002933
crossref_primary_10_1016_S0749_4041_09_79253_X
crossref_primary_10_1016_j_surge_2013_09_008
crossref_primary_10_1016_j_jvs_2023_03_026
crossref_primary_10_1179_1743132813Y_0000000172
crossref_primary_10_1016_j_ejvs_2014_08_012
crossref_primary_10_1007_s11883_015_0528_3
crossref_primary_10_1016_j_ejvs_2013_08_014
crossref_primary_10_1016_S0304_5412_11_70025_7
crossref_primary_10_1155_2012_340798
crossref_primary_10_23736_S0392_9590_21_04825_2
crossref_primary_10_1016_j_avsg_2014_08_028
crossref_primary_10_1016_j_avsg_2013_08_007
crossref_primary_10_1177_2396987320932065
crossref_primary_10_1227_NEU_0000000000000261
crossref_primary_10_1016_j_ejvs_2015_07_019
crossref_primary_10_1016_j_apmr_2019_12_013
crossref_primary_10_1016_j_pcad_2022_10_002
crossref_primary_10_1016_j_jvs_2017_09_021
crossref_primary_10_1016_j_ejvs_2015_03_034
crossref_primary_10_1016_j_ejvs_2015_03_035
crossref_primary_10_1212_WNL_0b013e31822b00cf
crossref_primary_10_1227_NEU_0000000000000150
crossref_primary_10_1016_j_jns_2018_02_034
crossref_primary_10_1016_j_ejvs_2018_06_036
crossref_primary_10_1017_S0317167100010210
crossref_primary_10_1016_j_ejvs_2017_06_017
crossref_primary_10_1002_ana_23553
crossref_primary_10_1093_neuros_nyy557
Cites_doi 10.1161/str.25.11.7974549
10.1212/01.WNL.0000110311.09970.83
10.1001/archinte.167.22.2417
10.1161/str.29.10.2118
10.1016/S0140-6736(07)61448-2
10.1016/S1474-4422(07)70248-X
10.1016/S0140-6736(97)09292-1
10.1016/S0140-6736(03)12228-3
10.1161/strokeaha.107.505438
10.1001/jama.284.22.2901
10.1161/strokeaha.107.488833
10.1161/str.31.3.601
10.1212/01.WNL.0000170368.82460.b4
10.1016/S1474-4422(07)70250-8
10.1016/j.ejvs.2005.02.045
10.1159/000113732
10.1056/NEJM199811123392002
10.1016/S1474-4422(07)70274-0
10.1161/01.cir.0000020190.45892.75
10.1136/bmj.37991.635266.44
10.1001/archneur.62.3.393
10.1161/01.str.0000133129.58126.67
10.1002/9780470752883
10.1161/str.30.6.1208
10.1161/01.str.0000147040.20446.f6
ContentType Journal Article
Copyright 2009 INIST-CNRS
Copyright_xml – notice: 2009 INIST-CNRS
DBID AAYXX
CITATION
IQODW
CGR
CUY
CVF
ECM
EIF
NPM
7X8
DOI 10.1161/STROKEAHA.109.548032
DatabaseName CrossRef
Pascal-Francis
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList CrossRef
MEDLINE - Academic
MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1524-4628
EndPage 2731
ExternalDocumentID 19498196
21782441
10_1161_STROKEAHA_109_548032
Genre Research Support, Non-U.S. Gov't
Journal Article
Comparative Study
GroupedDBID ---
.3C
.55
.GJ
.XZ
.Z2
01R
0R~
123
1J1
2WC
3O-
40H
4Q1
4Q2
4Q3
53G
5RE
5VS
6PF
71W
77Y
7O~
A9M
AAAAV
AAAXR
AAGIX
AAHPQ
AAIQE
AAJCS
AAMOA
AAMTA
AAQKA
AAQQT
AARTV
AASCR
AASOK
AAUEB
AAXQO
AAYEP
AAYJJ
AAYXX
ABASU
ABBUW
ABDIG
ABJNI
ABPXF
ABQRW
ABVCZ
ABXVJ
ABXYN
ABZAD
ABZZY
ACCJW
ACDDN
ACDOF
ACEWG
ACGFS
ACGOD
ACILI
ACLDA
ACWDW
ACWRI
ACXJB
ACXNZ
ACZKN
ADBBV
ADFPA
ADGGA
ADGHP
ADHPY
ADNKB
AE3
AE6
AEBDS
AEETU
AENEX
AFBFQ
AFDTB
AFEXH
AFFNX
AFMBP
AFNMH
AFSOK
AFUWQ
AGINI
AHMBA
AHOMT
AHQNM
AHQVU
AHRYX
AHVBC
AIJEX
AINUH
AJCLO
AJIOK
AJNWD
AJNYG
AJZMW
AKCTQ
AKULP
ALKUP
ALMA_UNASSIGNED_HOLDINGS
ALMTX
AMJPA
AMKUR
AMNEI
AOHHW
AOQMC
AYCSE
BAWUL
BCGUY
BOYCO
BQLVK
BS7
C45
CITATION
CS3
DIK
DIWNM
DU5
DUNZO
E.X
E3Z
EBS
EEVPB
EJD
ERAAH
EX3
F2K
F2L
F2M
F2N
F5P
FCALG
FL-
FW0
GNXGY
GQDEL
GX1
H0~
H13
HLJTE
HZ~
IKREB
IKYAY
IN~
IPNFZ
J5H
JF9
JG8
JK3
JK8
K8S
KD2
KMI
KQ8
L-C
L7B
M18
N4W
N9A
N~7
N~B
N~M
O9-
OAG
OAH
OB3
OCUKA
ODA
ODMTH
OGROG
OHYEH
OK1
OL1
OLG
OLH
OLU
OLV
OLY
OLZ
OPUJH
ORVUJ
OUVQU
OVD
OVDNE
OVIDH
OVLEI
OVOZU
OWBYB
OWU
OWV
OWW
OWX
OWY
OWZ
OXXIT
P-K
P2P
PQQKQ
R58
RAH
RIG
RLZ
S4R
S4S
T8P
TEORI
TSPGW
V2I
VVN
W3M
W8F
WH7
WOQ
WOW
X3V
X3W
X7M
XXN
XYM
YFH
YHZ
YQJ
YYP
ZB8
ZGI
ZZMQN
IQODW
CGR
CUY
CVF
ECM
EIF
NPM
7X8
ADKSD
ID FETCH-LOGICAL-c437t-2d9623135a5d83070d6d4dcd113c8d195e33b9336b685292adc63afa805467313
ISSN 0039-2499
1524-4628
IngestDate Mon Sep 08 08:29:51 EDT 2025
Mon Jul 21 06:01:07 EDT 2025
Mon Jul 21 09:14:33 EDT 2025
Tue Jul 01 03:03:46 EDT 2025
Thu Apr 24 23:12:24 EDT 2025
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 8
Keywords Arterial disease
Vascular disease
Carotid stenosis
Stroke
Nervous system diseases
Prognosis
Central nervous system disease
Risk factor
Cardiovascular disease
stroke care
Cerebrovascular disease
Cerebral disorder
Language English
License CC BY 4.0
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c437t-2d9623135a5d83070d6d4dcd113c8d195e33b9336b685292adc63afa805467313
Notes ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
PMID 19498196
PQID 67535242
PQPubID 23479
PageCount 5
ParticipantIDs proquest_miscellaneous_67535242
pubmed_primary_19498196
pascalfrancis_primary_21782441
crossref_citationtrail_10_1161_STROKEAHA_109_548032
crossref_primary_10_1161_STROKEAHA_109_548032
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2009-08-01
PublicationDateYYYYMMDD 2009-08-01
PublicationDate_xml – month: 08
  year: 2009
  text: 2009-08-01
  day: 01
PublicationDecade 2000
PublicationPlace Hagerstown, MD
PublicationPlace_xml – name: Hagerstown, MD
– name: United States
PublicationTitle Stroke (1970)
PublicationTitleAlternate Stroke
PublicationYear 2009
Publisher Lippincott Williams & Wilkins
Publisher_xml – name: Lippincott Williams & Wilkins
References e_1_3_2_20_2
e_1_3_2_21_2
e_1_3_2_22_2
e_1_3_2_23_2
e_1_3_2_24_2
e_1_3_2_25_2
e_1_3_2_9_2
e_1_3_2_15_2
e_1_3_2_8_2
e_1_3_2_16_2
e_1_3_2_7_2
e_1_3_2_17_2
e_1_3_2_6_2
e_1_3_2_18_2
e_1_3_2_19_2
e_1_3_2_1_2
e_1_3_2_10_2
e_1_3_2_5_2
e_1_3_2_11_2
e_1_3_2_4_2
e_1_3_2_12_2
e_1_3_2_3_2
e_1_3_2_13_2
e_1_3_2_2_2
e_1_3_2_14_2
References_xml – ident: e_1_3_2_12_2
  doi: 10.1161/str.25.11.7974549
– ident: e_1_3_2_8_2
  doi: 10.1212/01.WNL.0000110311.09970.83
– ident: e_1_3_2_20_2
  doi: 10.1001/archinte.167.22.2417
– ident: e_1_3_2_9_2
  doi: 10.1161/str.29.10.2118
– ident: e_1_3_2_21_2
  doi: 10.1016/S0140-6736(07)61448-2
– ident: e_1_3_2_23_2
  doi: 10.1016/S1474-4422(07)70248-X
– ident: e_1_3_2_2_2
  doi: 10.1016/S0140-6736(97)09292-1
– ident: e_1_3_2_3_2
  doi: 10.1016/S0140-6736(03)12228-3
– ident: e_1_3_2_17_2
  doi: 10.1161/strokeaha.107.505438
– ident: e_1_3_2_6_2
  doi: 10.1001/jama.284.22.2901
– ident: e_1_3_2_10_2
  doi: 10.1161/strokeaha.107.488833
– ident: e_1_3_2_25_2
  doi: 10.1161/str.31.3.601
– ident: e_1_3_2_11_2
  doi: 10.1212/01.WNL.0000170368.82460.b4
– ident: e_1_3_2_24_2
  doi: 10.1016/S1474-4422(07)70250-8
– ident: e_1_3_2_5_2
  doi: 10.1016/j.ejvs.2005.02.045
– ident: e_1_3_2_19_2
  doi: 10.1159/000113732
– ident: e_1_3_2_1_2
  doi: 10.1056/NEJM199811123392002
– ident: e_1_3_2_22_2
  doi: 10.1016/S1474-4422(07)70274-0
– ident: e_1_3_2_15_2
  doi: 10.1161/01.cir.0000020190.45892.75
– ident: e_1_3_2_7_2
  doi: 10.1136/bmj.37991.635266.44
– ident: e_1_3_2_18_2
  doi: 10.1001/archneur.62.3.393
– ident: e_1_3_2_16_2
  doi: 10.1161/01.str.0000133129.58126.67
– ident: e_1_3_2_14_2
  doi: 10.1002/9780470752883
– ident: e_1_3_2_13_2
  doi: 10.1161/str.30.6.1208
– ident: e_1_3_2_4_2
  doi: 10.1161/01.str.0000147040.20446.f6
SSID ssj0002385
Score 2.363487
Snippet Background and Purpose— Few data are available on very early stroke recurrence evaluated within the first hours after onset of symptoms and outcome for...
Few data are available on very early stroke recurrence evaluated within the first hours after onset of symptoms and outcome for unselected patients with...
SourceID proquest
pubmed
pascalfrancis
crossref
SourceType Aggregation Database
Index Database
Enrichment Source
StartPage 2727
SubjectTerms Aged
Aged, 80 and over
Biological and medical sciences
Carotid Stenosis - complications
Carotid Stenosis - epidemiology
Cohort Studies
Female
Humans
Ischemic Attack, Transient - epidemiology
Ischemic Attack, Transient - etiology
Ischemic Attack, Transient - prevention & control
Male
Medical sciences
Middle Aged
Nervous System Diseases - epidemiology
Nervous System Diseases - etiology
Nervous System Diseases - prevention & control
Neurology
Neurosurgery
Risk Factors
Secondary Prevention
Skull, brain, vascular surgery
Stroke - epidemiology
Stroke - etiology
Stroke - prevention & control
Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases
Time Factors
Vascular diseases and vascular malformations of the nervous system
Title High Risk of Early Neurological Recurrence in Symptomatic Carotid Stenosis
URI https://www.ncbi.nlm.nih.gov/pubmed/19498196
https://www.proquest.com/docview/67535242
Volume 40
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1db9MwFLXKkBASQnzTAcMPvE0eixM7yWMFhapoILZO2lvkxM4UsSVVkz5sv557YydNYRMfL1EVx7bkc3p9r319TMg7iJFFmEvBDJ5TDjgPmeJGMJ7DbJFGOKPjeeejr3J2GszPxNlolA-yltZNepBd33iu5H9QhXeAK56S_Qdk-0bhBfwGfOEJCMPzrzDGJI0-Ody0UsWtPmVnz1a4mG5lZItyv766XDaVlWjF23qaQu8DxmVVF_XQRz1pVtWP1vX04vBwuBDrri7u8mBtarXSK6Ur9rnSNu92elHUva0_rrTdi_94vjbXDHc6ut2eSdl_NccrBrC4KrVb0wfebi1IxH06HMwnzojygOGZ16GVtaJMjk3R0GSGVhzgd1su0ZafLI6_fZlOZhMUvjpAdTq7HjqAd3nZ4uvFQQwD84uwto10XNEdcpeH4GPh5v33jao8uC3CHauETt_f1GUrLmsb2fJgHixVDYDm9haU28OU1l1ZPCIPXZxBJ5Y0j8nIlE_IvSOXSfGUzJE7FLlDq5y23KFD7tANd2hR0gF3qOMO7bjzjJx-mi4-zJi7V4NlgR82jOsYnF7PF0roCG2-ljrQmfY8P4u0Fwvj-yn8iWUqI8FjrnQmfZWrCNx7GULF52SnrErzklDfh_DVqDTW8jBIU5kanuZShYrnWujMjInfjVWSOdF5vPvkImmDT-kl_WBjLkRiB3tMWF9raUVX_vD93hYMfSWItyPwX70xedvhkoD5xD0xVZpqXScQL0MIEkATLyxcmw4d3Lu3lrwi9zf8f012mtXavAEXtUn3Wn79BGZojFQ
linkProvider Colorado Alliance of Research Libraries
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=High+risk+of+early+neurological+recurrence+in+symptomatic+carotid+stenosis&rft.jtitle=Stroke+%281970%29&rft.au=Ois%2C+Angel&rft.au=Cuadrado-Godia%2C+Elisa&rft.au=Rodr%C3%ADguez-Campello%2C+Ana&rft.au=Jimenez-Conde%2C+Jordi&rft.date=2009-08-01&rft.eissn=1524-4628&rft.volume=40&rft.issue=8&rft.spage=2727&rft_id=info:doi/10.1161%2FSTROKEAHA.109.548032&rft_id=info%3Apmid%2F19498196&rft.externalDocID=19498196
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0039-2499&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0039-2499&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0039-2499&client=summon